This study highlights the relevant clinical overlap between NDM-CLCN1 and NDM-SCN4A patients and warrants the use of early and broad genetic investigation for the precise identification of the NDM subtype. This evidence concerns the gene SCN4A and neonatal diabetes mellitus.